Search Results 21-30 of 8412 for Apixaban

  1. A Study To Learn How Well The Study Treatment Asundexian Works And How Safe It Is Compared To Apixaban To Prevent Stroke Or Systemic Embolism In People With Irregular And Often Rapid Heartbeat (Atrial Fibrillation), And At Risk For Stroke - Mayo Clinic

    A Study To Learn How Well The Study Treatment Asundexian Works And How Safe It Is Compared To Apixaban To Prevent Stroke Or Systemic Embolism In People With ...

  2. Anticoagulant Risk Explored - Mayo Clinic News Network

    ... apixaban has the lowest rate of GI bleeding at all age levels. Patients using apixaban were 61 percent less likely to report GI bleeding then those on ...

  3. Deep Vein Thrombosis (DVT) Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine whether prescribing apixaban (Eliquis®) is more effective in treating and preventing pulmonary embolisms and ...

  4. Anticoagulation In ICH Survivors For Stroke Prevention And Recovery - Mayo Clinic

    The primary purpose of this study is to determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ...

  5. Stroke Prevention Clinical Trials - Mayo Clinic Research

    The primary purpose of this study is to determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ...

  6. Deep Vein Thrombosis Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine whether prescribing apixaban (Eliquis®) is more effective in treating and preventing pulmonary embolisms and ...

  7. AtRial Cardiopathy And Antithrombotic Drugs In Prevention After Cryptogenic Stroke - Mayo Clinic

    About this study. Objectives - Primary: To test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in patients with ...

  8. Golden Calf Trial - Mayo Clinic

    The purpose of this study is to determine whether prescribing apixaban (Eliquis®) is more effective in treating and preventing pulmonary embolisms and ...

  9. Mayo Clinic Minute: Research shows newer blood thinners have lower risk of kidney function decline

    "And what we see is that patients taking the newer class of drugs – apixaban, rivaroxaban and dabigatran – had lower rates of kidney function decline in ...

  10. Pulmonary Embolism Clinical Trials - Mayo Clinic Research

    This randomized phase III trial studies the best dose of apixaban and how well it works in preventing secondary cancer related blood clots in cancer patients ...